You are here: vision-research.eu » People » Research Groups » Netherlands » Dias, Aylvin
DSM Ahead is the Materials Scienece R&D centre for DSM. This research centre performs work for DSM Biomedical.
From contact lenses to bioresorbable drug delivery systems, DSM Biomedical provides biomaterials innovation and market insight that turn promising product concepts into viable medical solutions for better eye health. As a pioneer and industry leader in biomedical polymers, customized drug delivery systems, contract R&D and manufacturing services for ophthalmic applications.
Aylvin Dias
[more information]
DSM Ahead
Urmonderbaan 22
Geleen, 6167 RD
The Netherlands
Phone: 00 31 464761067
E-mail:
Aylvin.dias[at]dsm.com
Website:
http://www.dsm.com
Having a superior understanding of chemical structure property relationships, DSM Biomedical ensures the material needs of its partner translate into superior product performance. Increasing end of day comfort, decreasing infections from new resistant bacterial strains and other performance factors such as increasing lubricity for dry eye patients, are the focus of next generation materials being produced at DSM Biomedical.
DSM Biomedical offers products and manufacturing processes designed to help our partners successfully navigate an evolving industry environment, including:
DSM Biomedical works closely with industry partners to create customized drug delivery systems based on proprietary technologies, offering the following products for advanced ocular drug delivery:
By applying DSM’s materials science expertise to the most challenging unmet clinical needs in ophthalmology, DSM Biomedical developed the Trancerta™ Drug Delivery portfolio to include the company’s proprietary bioresorbable material platforms as well as an extensive in-house library of synthesis methods, formulation and processing techniques. The material portfolio includes:
DSM Biomedical offers hydrophilic and antimicrobial coatings for intraocular lens delivery systems/delivery cartridges.